1. ADAR-mediated RNA editing regulates PVR immune checkpoint in colorectal cancer.
- Author
-
Qian, Cheng-Jia, He, Yu-Shan, Guo, Tao, Tao, Ji, Wei, Zhi-Yuan, Zhang, Jia-Li, Bao, Chuanqing, and Chen, Jian-Huan
- Subjects
- *
RNA editing , *GENE expression , *IMMUNE checkpoint proteins , *COLORECTAL cancer , *PROGRAMMED cell death 1 receptors , *DACTINOMYCIN - Abstract
Recent studies have revealed that tumor immunotherapy resistance is influenced by ADAR-mediated RNA editing, but its targets remain unelucidated. Our current study identified the poliovirus receptor (PVR) oncogene, which encodes an immune checkpoint in colorectal cancer (CRC), as a potential target for RNA editing. We performed transcriptome sequencing analysis and experimental validation in two Chinese CRC cohorts. PVR and ADAR expressions significantly increased in CRC tumors and showed positive correlations in both cohorts, coupled with upregulated PVR RNA editing in CRC tumors. Manipulation of ADAR expression by over-expression or knockdown substantially changed PVR expression and RNA editing in HTC116 CRC cells. Luciferase reporter and actinomycin D assays further revealed that RNA editing in PVR 3′-UTR could upregulate PVR RNA expression, probably by increasing the RNA stability. By increasing PVR expression, ADAR-mediate RNA editing might contribute to tumor- and immune-related gene functions and pathways in CRC. Moreover, a signature combining PVR RNA editing and expression showed promising predictive performance in CRC diagnosis in both Chinese CRC cohorts. Our findings thus highlight the importance of ADAR-mediated RNA editing in PVR up-regulation in CRC tumors and provide new insight into the application of PVR RNA editing as a novel diagnostic biomarker for CRC. • Immune checkpoint PVR was identified as a novel target of ADAR-mediated RNA editing in two Chinese CRC cohorts. • Elevated ADAR expression significantly upregulated PVR RNA editing and expression in CRC. • RNA editing in the PVR 3′-UTR significantly increased the RNA expression, probably by increasing RNA stability. • A signature combining PVR RNA editing and expression showed promising performance in CRC diagnosis in both Chinese cohorts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF